United Biopharma United BioPharma is a company dedicated to the development and commercialization of monoclonal antibodies. | Ascentage Pharma Ascentage Pharma Group International (亚盛闘棄集團) is a biopharmaceutical company that is engaged in discovering, developing, and commercializing therapies. | ![]() Epizyme Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors. | ![]() Loxo Oncology Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations. | ||
Founding Date | Founding Date 2013 | Founding Date 1953 | Founding Date 2017 | Founding Date 2007 | Founding Date 2013 |
Type | Type Private | Type Subsidiary | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations TW HQ Yangzhou Shi, CN Hauppauge, US | Locations Suzhou, CN HQ Guangzhou Shi, CN Suzhou Shi, CN Taizhou, CN Rockville, US | Locations Cambridge, US HQ | Locations Stamford, US HQ Alcobendas, ES Boulder, US New York, US South San Francisco, US | |
Employees | Employees 393% decrease | Employees 17,3684% decrease | Employees 567 | Employees 20364% increase | Employees 65610% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥574.1m (FY, 2025) | Revenue (est.) $37.4m (FY, 2021) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥48.9m (FY, 2025) | Cost of goods $10.5m (FY, 2021) | Cost of goods N/A |
Net income | Net income N/A | Net income N/A | Net income (¥1.2b) (FY, 2025) | Net income ($251.1m) (FY, 2021) | Net income ($148.9m) (FY, 2017) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 237.5m | Total funding raised $ 51.5m | Total funding raised $ 57m |
Janssen is a company providing prescription pharmaceutical products.
View companyAscentage Pharma Group International (亚盛闘棄集團) is a biopharmaceutical company that is engaged in discovering, developing, and commercializing therapies.
View company
Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors.
View company
Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.
View company